CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Autor: Cui, Qingya1,2 (AUTHOR), Qian, Chongsheng1,2 (AUTHOR), Xu, Nan3,4 (AUTHOR), Kang, Liqing3,4 (AUTHOR), Dai, Haiping1,2 (AUTHOR), Cui, Wei1,2 (AUTHOR), Song, Baoquan1,2 (AUTHOR), Yin, Jia1,2 (AUTHOR), Li, Zheng1,2 (AUTHOR), Zhu, Xiaming1,2 (AUTHOR), Qu, Changju1,2 (AUTHOR), Liu, Tianhui1,5 (AUTHOR), Shen, Wenhong1,2 (AUTHOR), Zhu, Mingqing1,2 (AUTHOR), Yu, Lei3,4 (AUTHOR) ylyh188@163.com, Wu, Depei1,2 (AUTHOR) drwudepei@163.com, Tang, Xiaowen1,2 (AUTHOR) tangxiaowen@suda.edu.cn
Zdroj: Journal of Hematology & Oncology. 5/25/2021, Vol. 14 Issue 1, p1-5. 5p.
Databáze: Academic Search Ultimate